SUDARSHAN PHARMA INDUSTRIES
Back to Cashflow Statement
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹0.37 Cr | ₹-12 Cr | ₹11 Cr | ₹-1.02 Cr | ₹-0.01 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹0.37 Cr |
| Mar2024 | ₹-12 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹-1.02 Cr |
| Mar2021 | ₹-0.01 Cr |
How is Net Cash Inflow / Outflow of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.37 Cr | Positive | |
| Mar2024 | ₹-12 Cr | Negative | |
| Mar2023 | ₹11 Cr | Positive | |
| Mar2022 | ₹-1.02 Cr | Negative | |
| Mar2021 | ₹-0.01 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹1,044.2 Cr | 1.9% | 4.7% | 40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | 1.9% |
4.7% |
40.9% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses